FindTrial
Sign In

Placebo to Glimepiride

DRUG4 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Type 2 Diabetes Mellitus

Phase 3

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)
CompletedNCT01189890
Merck Sharp & Dohme LLCType 2 Diabetes Mellitus
Start: 2010-08-16End: 2012-10-31Updated: 2017-06-05
A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)
TerminatedNCT01477853
Merck Sharp & Dohme LLCType 2 Diabetes Mellitus
Start: 2011-10-24End: 2012-12-04Updated: 2018-07-26
Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
CompletedNCT01999218
Merck Sharp & Dohme LLCType 2 Diabetes Mellitus
Start: 2013-12-16End: 2017-04-18Updated: 2019-04-02
A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).
CompletedNCT02033889
Merck Sharp & Dohme LLCType 2 Diabetes Mellitus
Start: 2013-12-13End: 2017-08-03Updated: 2018-09-10

Related Papers

Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity
Diabetes Therapy2023-02-012 citations
Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials
Diabetes Therapy2020-07-0914 citations
Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Seven Phase 3 Randomized Controlled Trials.
2020-05-0518 citations
Efficacy and safety of ertugliflozin across racial groups in patients with type 2 diabetes mellitus
Current Medical Research and Opinion2020-04-2310 citations
Efficacy and safety of ertugliflozin in Hispanic/Latino patients with type 2 diabetes mellitus
Current Medical Research and Opinion2020-04-233 citations
Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trials
Diabetologia2020-03-3140 citations
Efficacy and safety of ertugliflozin in East/Southeast Asian patients with type 2 diabetes mellitus.
2020-01-039 citations
Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studies
Diabetes and Vascular Disease Research2019-05-1325 citations
Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials
Cardiovascular Diabetology2019-05-0720 citations
Results of VERTIS SU extension study: safety and efficacy of ertugliflozin treatment over 104 weeks compared to glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin
Current Medical Research and Opinion2019-02-1450 citations
Long‐term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104‐week VERTIS MET trial
Diabetes Obesity and Metabolism2019-01-0863 citations
A Pooled Analysis of the Efficacy and Safety of Ertugliflozin as Add-On Therapy to Metformin
Diabetes2018-06-223 citations
Long-term efficacy and safety of ertugliflozin monotherapy in patients with inadequately controlled T2DM despite diet and exercise: VERTIS MONO extension study.
2018-02-2363 citations
Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study
Diabetes Therapy2017-12-27106 citations
Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET).
2017-10-02137 citations
Efficacy and Tolerability of Sitagliptin Compared with Glimepiride in Elderly Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control: A Randomized, Double-Blind, Non-Inferiority Trial.
2015-06-0124 citations